Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

UCB

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of UCB's 2013 CNS (central nervous system) sales performance.

UCB

Second TULIP trial resurrects AZ’s lupus drug anifrolumab

Second TULIP trial resurrects AZ’s lupus drug anifrolumab

BICLA has also been used in drug development programmes, for example with UCB’s lupus candidate epratuzumab, although that drug failed to show a significant impact on disease activity using the ... Benlysta has been a rare success in lupus, with a

Tecentriq’s triple negative breast cancer use among key CHMP nods

Tecentriq’s triple negative breast cancer use among key CHMP nods UCB’s Vimpat (lacosamide) also gained a thumbs up in the epilepsy market, with a recommendation in partial-onset seizures with or without secondary generalisation. ... On Friday the CHMP’s most notable ruling was a negative opinion for UCB and

CHMP blocks UCB/Amgen’s Evenity approval for osteoporosis

CHMP blocks UCB/Amgen’s Evenity approval for osteoporosis Another obstacle for drug. The main advisory committee for new drugs in the EU has rejected UCB and Amgen's application for their severe osteoporosis drug Evenity. ... void. Now, the EU rejection makes that task even harder. Amgen and UCB say they intend

The first, my last, my everything

The first, my last, my everything One of the most prominent advocates is UCB, whose pioneering reorganisation around ‘patient value creation’ put the company at the vanguard of the movement.

Amgen and UCB’s Evenity finally approved, but with label warnings

Amgen and UCB’s Evenity finally approved, but with label warnings Drug unlikely to match Prolia's revenues. Amgen and UCB’s novel osteoporosis treatment Evenity has been approved by the FDA, nearly two years after it was first submitted. ... Additional data from the FRAME trial helped change the FDA’s mind at the

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics